Abstract
The liver biopsy is one of the most commonly used and important diagnostic methods in clinical hepatology. Transjugular liver biopsy (TJLB) can safely used in patients with severe coagulopathy and/or prehepatic ascites, thereby expanding the indication of liver biopsy. However, there is currently no TJLB-specific procedure guidance, standard process for pathological sampling and tissue specimen processing in China. Therefore, the Chinese Society of Hepatology of the Chinese Medical Association invited experts in the relevant fields to compile a consensus regarding the indications, contraindications, procedure methods, pathological specimen collection, tissue process, and other issues with the aim to facilitate the more reasonable application of TJLB in clinical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
